Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0PO9X
|
||||
Former ID |
DNC007244
|
||||
Drug Name |
2-morpholino-6-(naphthalen-1-yl)-4H-pyran-4-one
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528738] | ||
Structure |
Download2D MOL |
||||
Formula |
C19H17NO3
|
||||
Canonical SMILES |
C1COCCN1C2=CC(=O)C=C(O2)C3=CC=CC4=CC=CC=C43
|
||||
InChI |
1S/C19H17NO3/c21-15-12-18(23-19(13-15)20-8-10-22-11-9-20)17-7-3-5-14-4-1-2-6-16(14)17/h1-7,12-13H,8-11H2
|
||||
InChIKey |
VSXKSTFHVOSHSV-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | DNA-dependent protein kinase catalytic subunit | Target Info | Inhibitor | [528738] | |
KEGG Pathway | Non-homologous end-joining | ||||
Cell cycle | |||||
NetPath Pathway | IL1 Signaling Pathway | ||||
Reactome | Nonhomologous End-Joining (NHEJ) | ||||
References | |||||
Ref 528738 | J Med Chem. 2007 Apr 19;50(8):1958-72. Epub 2007 Mar 20.Pyranone, thiopyranone, and pyridone inhibitors of phosphatidylinositol 3-kinase related kinases. Structure-activity relationships for DNA-dependent protein kinase inhibition, and identification of the first potent and selective inhibitor of the ataxia telangiectasia mutated kinase. | ||||
Ref 528738 | J Med Chem. 2007 Apr 19;50(8):1958-72. Epub 2007 Mar 20.Pyranone, thiopyranone, and pyridone inhibitors of phosphatidylinositol 3-kinase related kinases. Structure-activity relationships for DNA-dependent protein kinase inhibition, and identification of the first potent and selective inhibitor of the ataxia telangiectasia mutated kinase. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.